chrisvoncsefalvay/vaers-outcomes huggingface dataset:
From initial information received on 3/26/04 from a nurse regarding an adverse event occurring in the USA, it was reported that a 78 year old female patient received a TD ADS ADULT vaccination, lot number U1021AA, administered IM in the left deltoid on 3/18/04. At the time of vaccination the patient was taking Zestril, Lorazepam, Gas-X, and multivitamins. Seven days post immunization, the patient developed a red rash distal to the injection site radiating to her shoulder and elbow. She did not experience any respiratory distress. The patient was seen in the emergency room where a topical triamcinolone cream 1% was ordered four times a day. The patient's recovery status is unknown. From additional information received on 8/16/04 from the initial reporter, it was reported that the case was reviewed and the patient was contacted on 8/11/04. The patient stated that the hydrocortisone cream that was prescribed reduced the inflamed area, and within ten days the area was better with no untoward effects. No further information is anticipated, this case is considered closed.
Pt had a positive COVID test on 8/10/22; 8/16/22 admitted to hospital for AHRF; also found a large right sided spiculated lung mass; family opted for pt to have hospice care and transitioned to comfort care; pt passed away in the hospital.
TINGLING IN LEFT FOOT; LEFT LEG FELT HEAVY; PAIN IN LEFT FOOT; NO STRENGTH IN LEFT LEG; This spontaneous report received from a patient concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included thyroid, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, and expiry: UNKNOWN) dose was not reported, administered on 03-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAY-2021, the subject experienced tingling in left foot. On MAY-2021, the subject experienced left leg felt heavy. On MAY-2021, the subject experienced pain in left foot. On MAY-2021, the subject experienced no strength in left leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left leg felt heavy, no strength in left leg, tingling in left foot, and pain in left foot. This report was non-serious.
Abdominal pain, fever, diarrhea, malaise starting on 6/12 => diagnosed with complex appendicitis on 6/18 with intra-abdominal abscess
precancerous cells; lack of efficacy with GARDASIL; HPV; This spontaneous report was received from a 24 years old female pharmacist referring to herself. The patient's concurrent condition, medical history and concomitant therapy were not reported.  The pharmacist was the patient who received quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). On an unspecified date in 2008 (reported as when the patient was 12 years old), the patient was vaccinated with a complete series quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (strength, dose, route, lot number and expiration date were not reported) for prophylaxis (reported as routine vaccination). The patient was positive for human papillomavirus (HPV) as adult.  The patient reported a lack of efficacy with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). The patient sought medical attention with the physician. The patient was diagnosed with HPV on unknown date in 2018 when she had an abnormal PAP smear on routine visit. The patient said her PAP smear in 2019 was normal but the PAP smear in 2020 was also abnormal (Exact dates of PAP smears unknown). The patient had a colposcopy (with biopsy) on unknown date that showed precancerous cells but with no treatment as the physician said they were "not overly concerned and would continuing monitoring for now". The patient did not know what HPV type she tested positive for in 2018. The outcome of all events was not recovered. The causality between the events and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not provided.
infant recv vax & either spit or regurgitated rota shield on employee skin & employee devel diarrhea & vomiting;
had a seizure after the second shot; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (had a seizure after the second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SEIZURE (had a seizure after the second shot) (seriousness criterion medically significant). At the time of the report, SEIZURE (had a seizure after the second shot) outcome was unknown.            No concomitant medications were reported. No treatment details were provided. The adverse event was submitted via chat box mentioning about a person who experienced seizure after 2nd shot and questioned about the side effects.  Company comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Upon internal review on 16-Sep-2022 non-significant corrections performed to update case received from field; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
"Following the injection while still sitting at the chair, the client complained about feeling dizzy and head moved forward. The vaccination caught him and carried him with another EMS. Client had a brief episode of syncope. Once in a post op EMT area, he was alert and oriented again." "Client was able to talk and recall the incident. Vitals stable. Water offered and he said it will be helpful and he had sips of water. Client accompanied by wife and child. Client stated that he used to have syncope following vaccine injections previously. Wife to drive back home. Refused to be transported to the  hospital and stated that he is feeling better." Site Supervisor Report  Dose #2 due on 5/15
got the Shingles shot, then came down with Shingles / Suspected vaccination failure; then about a year later he came down with Shingles / Shingles on the right side of his face and under his right eyelid; Shingles in his mouth; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the Shingles shot, then came down with Shingles / Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: then about a year later he came down with Shingles / Shingles on the right side of his face and under his right eyelid) and oral herpes zoster (Verbatim: Shingles in his mouth). The outcome of the vaccination failure was unknown and the outcome of the shingles and oral herpes zoster were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and oral herpes zoster to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and oral herpes zoster to be related to Shingles vaccine.   Additional Information: GSK receipt date: 02-MAR-2023 This case was reported by a patient's wife via interactive digital media. The patient went to the emergency room and they told him what it was. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
I received the shot as described at about 0800 Wednesday morning. At about 1400 I began experiencing some minor chills. These chills increased until the point at about 1800 when they became severe, uncontrollable, and unaffected by my being dressed in multiple layers, under blankets, and using heating pads. This is also about the time that I began to experience increasingly severe pain in my spine, neck, skull, and face. It felt like pain was coming from the bones themselves, not the surrounding tissue, and it became very, very intense, so much so that I strongly considered coming in to the ER for it. I also experienced some mild lightheadedness, lack of appetite, and nausea. These symptoms continued for several hours, well into the night, and prevented me from being able to fall asleep. They eased somewhat after I soaked in a warm bath with some Epsom salts and baking soda added at about 0200 the next day. The bath ended the chills, but the bone pain persisted, though subsiding, throughout the morning. I was unable to come into work on Thursday due to this. Today I still feel a bit weak and achy.
3 diameter inch red spot; A spontaneous report was received from a consumer concerning a 72 years old, male patient who experienced 3 diameter inch red spot (Injection site erythema).   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     The patient received their first of two planned doses of mRNA-1273 (Batch number: 032L20A) on 23-Jan-2021 in the left arm for prophylaxis of COVID-19 infection.   On 2-Feb-2021 the patients experienced 3 diameter inch red spot in the same arm of the injection 10 days later. Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the event 3 diameter inch red spot was not reported.
pt recvd vax & 10mins p/vax pt noted scratching both upper arms & c/o itching @ inj site bilat; pt c/o progressive inc itching, frantic, scratching-no hives, dyspnea noted; DPH given
Moderna COVID-19 Vaccine EUA- Within 10 min, both ears turned blood red and were hot, neck area was slightly red and lips started to tingle.  Doctors on sight kept very close eye on me, the redness went down after about 15min or so, lips still tingled for a bit, stayed at sight for about 45 min, went home and was told to take Benadryl, took the Benadryl once home, within a half hour I had a mild headache. Through the night, my lips still tingled and I began itching, no hives.  Next day, I was a little fatigued and had some stomach nausea but felt worn out most of the day, the itching went away.  By the next day, I returned to work and felt fine.
Itching, numbness, and tingling of left arm. Vitals were stable. Neurological assessment unremarkable. Strength & ROMN equalin bilateral arms. No Pronator drift. PERRLA. Patient was observed for 30 minutes after vaccine administered. Reported symptoms were beginning to lessen prior to leaving., Spoke with patient later and she advised that symptoms fully resolved after 2 days.
started crying/screaming 45-60 mins following vax; not consolable lasted 6 hrs; mom wans't aware should be seen for this;
I have had issues with each dose. With each dose I have had a buzzing headache that lasts several weeks. 1st Dose - developed SIRVA in the left arm requiring months of rehab and a cortisone shot to alleviate extreme pain. The pain was so severe that I thought I was having a heart attack. 2nd Dose - Developed soreness and itchiness around and under both breasts, had it checked out by a breast specialist. 3rd Dose - Have developed Bell's Palsy, have extreme pain on the right side of my face and the right side of my face is frozen. Severe pain shooting down right side of neck.
p/vax pt started itching & by that evening swelling & redness @ inj site;lt arm above 5-6in above elbow;next AM dark bruising @ inj site;swelling, redness, itching spread around arm;burning , itching, swelling on lt arm;
Patient lethargy, no energy, not eating. Rush to ER where was given blood transfusion because acute anemia. More test were performed and later diagnosed with idiopathic autoimmune hemolytic anemia. She was given Ranitidine 15 mg take 1.5 ml by mouth twice a day for six month.
Within 7 hours of the shot, I got a fever of 102.3, severe body aches, severe headache, fatigue, dry cough, and shakiness.  Now it's 24 hours after the shot, and I have diarrhea, rash on neck, dizziness, weakness, a productive cough, severe body aches, severe headache, fatigue, and temp of 99.9
"Minutes after I take the vaccine, i feel numbness on my face.m, it last over 8 hours".; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 18Apr2021 at 14:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included season allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ethinylestradiol, norethisterone acetate (JUNEL FE 1.5/30) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 18Apr2021 at 14:45, minutes after she took the vaccine, she felt numbness on her "face.m". It lasted over 8 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event numbness on "face.m" was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
At approximately 1102, nurse administered second dose of 0.1ml dose of Jynneos vaccine Lot # FDP00014 via intradermal route to right forearm to client, and vaccine leaked while administering. Nurse notified clinic lead nurse regarding incident. At 1105 lead nurse did a medical consult via phone call to Dr. to notify of incident. Dr. advised to administer a second dose of Jynneos vaccine via intradermal route two inches away from first injection or via subcutaneous route. Lead nurse educated client that because there was leakage while administering vaccine, a repeat dose must be placed to other arm or two inches away from first dose. Patient verbalized understanding. At 1112 nurse re-administered a dose of 0.5ml of Jynneos Lot# FDP00014 via subcutaneous route to left upper outer arm. Client was educated on possible side effects after vaccine and to observe for adverse reactions. Client verbalized understanding. Client remained in the observation area for the recommended time frame. Client reported no symptoms. Client left facility with a steady gait.
Six hours after the shot the injection site plus almost the entire length started to get sore and it lasted for 48 hours. My other two really bad reactions were as follows: Eight hours after shot I was shivering and cold no matter how many clothes I put on or how high I turned up the heat. This lasted 6 more hours. One hour after the shivering stopped I was overheated and sweated PROFUSELY. This lasted another 8 hours. Then the overheating and sweating just stopped and I was fine. Ps. my sister and I got the same shot, same Lot#, same day and she had the same shivering for 6 hours but not the sweating.
inflammation from my elbow to the shoulder; pain in my arm; arm was swollen; arm was beet red; itchy; slight aches and pains for a couple days; physically exhausted; slight discomfort in arm; A spontaneous report was received from a  consumer  concerning a  72Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  events like slight discomfort in my arm, physically exhausted, slight aches and pains, arm itchy, term arm swollen, arm beet red, inflammation is from my elbow to the shoulder, pain in my arm.    The patient's medical history is not reported. No relevant concomitant medications were reported.        On 13th Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.      On date 13th Jan 2021, The patient experienced the events like slight discomfort in my arm, physically exhausted, slight aches and pains. On date 21st Jan 2021, the patient experienced the events like arm itchy, arm swollen, arm beet red, inflammation is from my elbow to the shoulder, pain in my arm.  Laboratory details not provided.       No treatment information was provided.       Action taken with mRNA-1273 in response to the events was not reported.       The outcome of the events like slight discomfort in my arm, physically exhausted were resolved on date 13th Jan 2021. The outcome of the event like slight aches and pains was resolved on date 15th Jan 2021. The outcome of the event like arm itchy, pain in my arm were resolved on date 22nd Jan 2021 The outcome of the events like arm swollen, arm beet red is unknown.
Patient developed throat itching and facial redness, swelling, and itching within one hour after receiving vaccine. Patient sent to urgent care and given IM steroid and course of antihistamines. Told to list FLUZONE as an allergy.
fully covid vaccinated as of 2/9/21.  tested covid positive on 5/13/21.
In mother's lap immediately following vaccination, child went limp, unresponsive, stopped breathing and became cyanotic around mouth.  RN picked up child, placed her in position for CPR and gently shook her while calling for help.  Child started weak cry after 15 seconds.  Oxygen at 4 liters/min administered.  Continued to improve until alert, playful, and vital sounds stable and consistent. Phoned primary md, examined by VCHD md before discharged home.
Information has been received on 23-MAR-2018 from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 11-FEB-2015, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended. On or about 26-AUG-2016, the patient was treated by a physician and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Onset of erythema, confluent papular rash on face, trunk and extremities.  Papules more scattered distally, extremities, palms/soles.
Information has been received from a registered nurse concerning a 12 month old male with a history of ear infection who on 5/28/03 was vaccinated IM in the right thigh with a first dose of varicella virus vaccine live (lot # 637676/0275M). Suspect vaccination included a first dose of MMR (lot # 639692/0635M) given IM in the right thigh. Concomitant vaccination included a fourth dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine (lot # 491188) given IM in the left thigh. There was no illness at the time of vaccination. On 4/4/04 (also reported as 4/5/04), the patient began to develop a rash on his face, neck and chest. On 4/5/04, the patient was seen in the office with a fever of 99.8 F and chicken pox blisters, which was reported as clinical chicken pox. It was noted that a clinical exam was performed. The physician prescribed calamine (+) camphor (+) diphenhydramine hydrochloride lotion, diphenhydramine hydrochloride (+) acetaminophen, and ibuprofen. It was reported that the patient had no adverse events following prior vaccination. There was no product quality complaint involved. Follow up information indicated that the patient recovered from chickenpox. No further information is available.
Dr saw at medical center on 11-14-08 with itching on scalp and noticed bump. Dev. bumps on ears-behind, on the forehead, chest, abd, back and today on legs and arms. Plan-Acyclovir 800mg one tablet po qid x 5 days. Do not get 2nd vaccine.
Hand Tremors, Headaches, Confusion, Hard to Speak, Severe Anxiety
Mom notified us 48 hours after vaccines that child had had hives and increased temp 101 degrees F - 102 degrees F 24 hrs after vaccine given. Her M. D. prescribed TYLENOL and BENADRYL and s/s resolved. She did bring him here 3-13-09 to look @ L shoulder where KINRIX given - slightly reddened, but WNL, however child pale, lethargic and per mother, problems with balance. Her M. D. was notified my me. His office is closed so he advised child go to ER. Mother said she would take child to ER. Unknown if these s/s were related to vaccines. Mother had also had hives, but she recovered.
Upon third vaccine administration,  epistaxis occurred of unknown cause. Pressure applied on tip of nose for approx. 5-6 minutes to stop bleeding. Bleeding stopped. No adverse reaction noted at the injection sites.
Right sided tinnitus, which has persisted ever since. Right sided blurry vision, which has also persisted, but is improving.
Discharge Provider: MD Primary Care Provider: DO Admission Date: 1/30/2023 Discharge Date: Feb 1, 2023  PRESENTING PROBLEM: Acute kidney injury [N17.9] COVID [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is a 77 y.o. male with past medical history significant for nonischemic cardiomyopathy, afib, HTN, right AKA presented to the ED with generalized weakness and some confusion. His wife was diagnosed with COVID and he has been having a cough and subjective fever. Given his symptoms and inability to get adequate care by his wife due to her COVID and assistants were not traveling to the house with their COVID, he presented to the ER for further evaluation.   He remained stable and did not require supplemental oxygen for his COVID. Workup was negative for alternative diagnoses. He worked with PT/OT who had some limited assessment as his prosthesis was at home, but ultimately recommended SNF. After discussion with family he previously did not do well with SNF as they could not meet his needs and therefore they wanted him to return home when stable. His wife felt able to meet his needs at this time as she feels recovered from COVID. CM able to arrange transport, and he was discharged home in stable condition on 2/1/23.
Slight sore throat developing into a very sore throat by (could hardly swallow) by 11:00 p.m. on 01/15/2010, gargled with salt and hot water or vinegar, honey and hot water. Have not contacted doctor as it is Sunday.  No fever.